Saturday, March 17, 2018
Company News: Page (1) of 1 - 02/13/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Health Canada approves Ipsen's Somatuline® Autogel® for the treatment of carcinoid syndrome in adult patients with neuroendocrine tumours (NETs)
(February 13, 2018)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Canada, Inc.,Medicine,Disease,healthcare,Cancer,Surgery,Medication,Science,Medical,Cancer,Business,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines